share_log

日本医生:小林制药推迟公布或考虑经济效益

Japanese doctor: Kobayashi Pharmaceutical delays announcement or considers economic benefits

Breakings ·  Mar 30 22:52
There was a gap of more than two months from the first health problem report to Kobayashi Pharmaceutical's announcement of a product recall. People in the Japanese medical community said that Kobayashi Pharmaceutical's failure to disclose it immediately may be due to economic considerations. According to information, the Japan Consumer Affairs Agency defines health food as food beneficial to health. It also includes the type of product in which the accident occurred, food with functional labels, and does not require national approval. In response, some Japanese doctors said that it is easy to mislead consumers.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment